Receptos, Inc. Press Releases

RCPT 
$125.81
*  
3.76
3.08%
Get RCPT Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading RCPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis
12/22/2014 8:00:00 AM - GlobeNewswire


Receptos Announces Full Exercise of Underwriters'' Option to Purchase Additional Shares and Completion of Underwritten Public Offering of Common Stock
11/24/2014 9:48:00 AM - GlobeNewswire


Receptos Announces Pricing of Underwritten Public Offering of Common Stock
11/18/2014 8:10:00 PM - GlobeNewswire


Receptos Announces Proposed Underwritten Public Offering of Common Stock
11/17/2014 4:01:00 PM - GlobeNewswire


Tocagen Appoints Faheem Hasnain as Chairman of the Board of Directors
11/14/2014 8:00:00 AM - PR Newswire
▲12.31 % Price Change since this news event. The Volume Ratio is 1.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Flagship VentureLabs™ Introduces Symbiota, Pioneer of Agricultural Innovation Through the Plant Microbiome
11/13/2014 8:30:00 AM - PR Newswire


Receptos to Present at Credit Suisse Healthcare Conference
11/6/2014 4:01:00 PM - GlobeNewswire


Receptos Provides Development Updates and Reports Third Quarter 2014 Financial Results
11/4/2014 7:00:00 AM - GlobeNewswire


Receptos to Present at Nomura BioPharma Conference
11/3/2014 4:01:00 PM - GlobeNewswire


Receptos to Hold Third Quarter 2014 Financial Results Conference Call and Webcast
10/29/2014 4:01:00 PM - GlobeNewswire


Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis
10/27/2014 4:01:00 PM - GlobeNewswire


Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody in Phase 2 Trial for Eosinophilic Esophagitis
10/3/2014 8:00:00 AM - GlobeNewswire